Treace Medical Concepts (TMCI) Cash & Equivalents Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.15% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 24.05% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -7.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 100.41% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -22.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 23.57% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -7.71% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 156.03% |
| 10 | Treace Medical Concepts | 234.79 Mn | 182.94 Mn | 37.41 Mn | -28.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.63% |
| Dec 31, 2025 | -5.66% |
| Sep 30, 2025 | -36.53% |
| Jun 30, 2025 | -55.71% |
| Mar 31, 2025 | 43.26% |
| Dec 31, 2024 | -12.57% |
| Sep 30, 2024 | 66.39% |
| Jun 30, 2024 | 51.07% |
| Mar 31, 2024 | -68.48% |
| Dec 31, 2023 | -33.33% |
| Jun 30, 2023 | -88.15% |
| Mar 31, 2023 | -69.93% |
| Dec 31, 2022 | -81.60% |
| Jun 30, 2022 | -15.12% |
| Mar 31, 2022 | 507.25% |
| Dec 31, 2021 | 485.39% |
| Sep 30, 2021 | 610.96% |
| Jun 30, 2021 | 1,060.81% |
| Mar 31, 2021 | 52.96% |